NOVELION THERAPEUTICS INC. NVLN Cash Flow

Novelion therapeutics inc. (NVLN)

CashFlow / Quarterly

Mar'19	Dec'18	Sep'18	Jun'18	Mar'18	Dec'17	Sep'17	Jun'17	Mar'17	Dec'16	Sep'16	Jun'16	Mar'16	Dec'15	Sep'15	Jun'15	Mar'15	Dec'14	Sep'14	Jun'14	Mar'14	Dec'13	Sep'13	Jun'13	Mar'13	Dec'12	Sep'12	Jun'12	Mar'12	Dec'11	Sep'11	Jun'11	Mar'11	Sep'10	Jun'10
Cash used in operating activities
Net Income (Loss) Attributable to Parent
-31,800	-19,402	-24,808	-31,262	-32,828	-24,568	-49,744	-21,436	-30,962	-19,920	-5,936	-5,120	-21,894	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-10,277	-	-9,106	-6,145	-8,549	-697	-1,015
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:
Depreciation
361	361	421	443	475	548	478	484	490	179	24	23	38	-	-	-	-	-	-	-	-	-	230	252	235	-	-	-	-	-	-	370	342	306	303
Non-cash lease expense
600	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Amortization of intangible assets
6,300	6,278	6,274	6,274	6,274	6,274	6,274	6,273	6,231	2,134	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Stock-based compensation
645	599	619	936	906	1,118	926	1,094	1,399	544	217	36	0	0	0	1,965	365	303	179	419	552	320	137	94	48	59	140	4,831	721	690	690	664	929	618	574
Non-cash interest expense
12,205	10,166	10,358	9,953	9,193	8,749	8,400	8,063	7,742	2,676	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net loss and comprehensive loss
-	-	-	-	-	-	-	-	-	-	-5,936	-5,120	-	-	-2,682	-10,751	-5,896	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net loss and comprehensive loss
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-4,932	-8,638	-6,462	-	-7,396	-6,199	-6,427	-	81,460	-16,304	-	-	-	-	-	-	-
Depreciation
-	-	-	-	-	-	-	-	-	-	24	23	-	-	141	179	188	-	222	229	229	-	-	-	-	-	238	371	-	-	-	-	-	-	-
Depreciation
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	408	-	328	-	-	-	-
Unrealized foreign exchange loss
-530	-	-1,535	-732	-438	-	-182	305	72	-	-244	-58	69	-	-7	-55	162	8	11	-36	-58	-50	-69	74	-209	-74	151	-46	-197	-29	-206	-64	168	425	-1,019
Amortization of debt issuance costs and debt discount
1,752	-	108	109	18	-	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Fair value loss on investment
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	8	9	-	-	-
Recovery on assets held for sale
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	153	-	-	-	-	-	-	-	-	-	-
Recovery on assets held for sale
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	37	22	-	-	-	-	-	-	-	-	-	-	-
Gain on sale of discontinued operations (Note 12)
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	310	0	287	456	-	101,381	-	-	-	0	-	-	-	-
Deferred income taxes
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	395	2,278	602	942	2,807
Write-down of property, plant and equipment
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	-	-	-
Loss on sale of long-lived assets
-	-	-	-	-	-	-	-	-	-	-51	9	-	-	-7	0	-	-	0	-	-	-	4	-	-	-	-	-	-	-	-	-	-	0	317
Fair value loss on investment
-	-	-	-	-	-	-	-	-	-	0	2,256	-12,960	-	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Deferred income taxes
0	-89	27	913	6	32	118	17	-29	38	-262	5	5	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Other non-cash operating activities
-8	4	-16	4	5	67	2	4	10	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Deferred rent
-	-	-	-	-	-	-	-	-	-	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Deferred income taxes
-	-	-	-	-	-	-	-	-	-	262	-5	-	-	-4	-5	-4	-	416	-23	-214	-164	-108	-189	-269	-179	-949	-458	-193	-	-	-	-	-	-
Impairment of long-lived assets
-	-	-	-	-	-	-	-	-	-	0	-	-	-	11	-	-	-	0	-	-	-	-	-	-	-	1,056	-	-	-	-	-	-	-	-
Fair value change in contingent consideration (Notes 7, 14)
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-24	-761	24	-512	-	-	-	-	-	-	-	-	-	-
Changes in assets and liabilities:
Accounts receivable
-1,924	7,307	3,228	2,336	-6,126	7,675	1,070	2,006	2,101	900	-136	50	79	32	-26	45	-61	51	-4	64	-184	-148	47	-1,184	-1,021	-6,277	787	-1,166	-121	-214	-3,101	3,709	-1,423	-3,952	4,027
Inventories
1,679	-76	-996	517	2,255	-6,080	4,924	549	-5,474	-2,079	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	1	-1,318	531	425	-795	-309	-1,602	588	-273	-1,067
Secured note receivable - current
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	250	247
Prepaid expenses and other assets
-1,514	342	410	720	2,908	-18,784	-1,187	-58	488	-544	-218	-57	114	220	-365	-260	-37	267	-228	-613	-236	157	-690	30	924	-475	-1,482	30	1,039	-	-	-	-	-	-
Long-term deposits and other assets
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-319	-361	-686	-592	305
Accounts payable
-901	-7,721	346	-3,799	454	-2,045	6,345	639	-8,871	2,838	-1,964	2,217	1,350	-1,616	-2,203	2,823	812	-434	-1,415	1,177	65	-913	486	-259	-2,230	-2,391	2,195	360	146	492	476	224	-956	383	-95
Accrued liabilities and other liabilities
-7,379	-1,729	-3,889	7,804	-8,635	-22,527	2,096	4,265	-3,657	-5,712	267	165	-1,109	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Deferred revenue
24,167	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Accrued restructuring
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	-615	485	-170	-436	-1,167	-30	-	2,838	-	-	-	0	-	-	-	-
Deferred income
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0
Other accrued liabilities
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-2,143	684	1,363
Net Cash Provided by (Used in) Operating Activities
8,150	-9,243	-12,060	-11,466	-22,731	-15,795	-12,407	-1,863	-24,834	-13,565	-7,005	-4,874	-8,912	-	-	-	-	18,026	-6,057	-6,460	-5,054	-	-5,032	-6,402	-	-8,158	-10,493	-11,191	-11,738	-2,170	-464	-4,735	-9,209	12,405	-1,696
Cash used in investing activities
Net proceeds from sale of discontinued operations (Note 12)
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	7,502	750	-	-	101,430	-	-	-	-	-	-	-	-
Purchases of property and equipment
0	7	53	174	208	31	163	287	273	40	0	46	69	9	0	0	0	-	0	25	-	-	129	-	-	-9	205	204	492	1,247	530	352	1,188	231	650
Loan receivable
-	-	-	-	-	-	-	-	-	-	0	3,000	-	-	2,200	3,460	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Income taxes receivable
-	-	-	-	-	-	-	-	-	-	0	0	-	-	0	0	33	-	0	0	9	332	204	-43	-15	32	1	-391	93	3	1,945	-2,098	-787	6,027	-2,823
Accrued liabilities
-	-	-	-	-	-	-	-	-	-	267	165	-	-	151	317	-209	-	84	360	-624	111	203	-16	-1,345	-2,959	150	-1,167	-1,876	-	881	1,663	-	-	-
Cash used in operating activities
-	-	-	-	-	-	-	-	-	-	-7,005	-4,874	-	-	-4,173	-5,192	-4,767	-	-	-	-	-	-	-	-9,286	-	-	-	-	-	-	-	-	-	-
Net proceeds from sale of long-lived assets
-	-	-	-	-	-	-	-	-	-	177	26	-	-	0	0	-	-	-	-	-	-137	30	19	190	-	25	-	-	-	8	9	-	0	0
Loan receivable - repayments
-	-	-	-	-	-	-	-	-	-	0	-	-	-	5,660	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net cash used in investing activities
-	-	-	-	-	-	-	-	-	-	177	-3,020	-69	-	3,460	-3,460	0	-	-	-	-	-	-	-	9,747	-	-	-	-	-	-	-	-	-	-
Net proceeds from sale of discontinued operations
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	-	-	-
Net proceeds from sale of other assets
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	250	-	0	-	-	-	-
Net proceeds from sale of long-lived assets
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	-317
Proceeds from mortgage receivable
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	5,874	0	0	955	1,049	3,822	0
Proceeds from contingent consideration (Notes 16)
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	5,544	4,445	26,593	9,564	8,483	6,995	9,557	9,004	6,457	6,404	6,980	8,926	8,192	4,634	8,889	4,321	5,479
Secured Note - advances (Note 3)
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Secured Note - repayments (Note 3)
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net cash used in investing activities
0	-7	-53	-174	-208	-31	-163	-287	-273	-	-	-	-	-	-	-	-	115	5,544	4,420	26,593	-	15,886	7,764	-	9,536	107,707	6,200	12,612	7,681	7,670	5,246	8,750	7,912	5,146
Cash provided by financing activities
Net proceeds from Shareholder Term Loan, net of debt discount
0	-	0	0	19,977	-	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Issuance of common shares
-9	-55	-3	415	-3	-65	124	-84	134	21,481	0	0	0	-	-	-	206	-	-	-	0	0	0	3,556	4,761	11,014	7,416	1,267	720	344	66	1,424	348	490	231
Payment of Shareholder Term Loan issuance costs
0	2,268	0	0	698	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Repayment of Bridge Loans
2,996	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Other
-	-	-	-	-	-	-	-	150	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Common shares repurchased, including fees
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	14,079	-	-	-	-	4,256	4,155	6,753	3,675	8,668	7,237
Cash distribution to common shareholders
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	200,000	-	-	-	-	-	-	-	-	-	-	-
Decrease in restricted cash
-	-	-	-	-	-	-	-	-	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Settlement of Backstop Agreement
-	-	-	-	-	-	-	-	-	0	0	0	15,000	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Aralez investment
-	-	-	-	-	-	-	-	-	0	0	0	45,000	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net cash (used in) provided by financing activities
-3,005	27,700	-3	415	19,276	-65	124	-234	284	-	-	-	-	-	-	-	-	-	509	0	-	-	-	-	-	-	7,416	1,267	720	-3,912	-4,089	-5,329	-3,327	-8,178	-7,006
Exchange rate effect on cash
1,620	-	-	-	216	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net increase (decrease) in cash and cash equivalents
6,765	-	-	-	-3,447	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Aralez Investment (Note 2(b))
-	-	-	-	-	-	-	-	-	-	0	0	-	-	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Issuance of common shares related to stock option exercises
-	-	-	-	-	-	-	-	-	-	0	0	-	-	563	4,739	-	-	509	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net cash provided by (used in) financing activities
-	-	-	-	-	-	-	-	-	-	0	-15,000	-30,000	-	563	4,739	206	-	-	-	0	-	0	-196,444	-9,318	-	-	-	-	-	-	-	-	-	-
Exchange rate effect on cash
-	-	-	-	-	820	-307	882	652	-284	-59	-19	13	-51	-122	-17	-77	-61	-101	64	-151	-101	52	-83	-182	-133	258	-136	2	43	-262	49	177	152	-236
Net decrease in cash and cash equivalents
-	-	-	-	-	-15,071	-12,753	-1,502	-24,171	35,871	-6,887	-22,913	-38,968	-5,244	-272	-3,930	-4,638	18,080	-105	-1,976	21,388	4,435	10,906	-195,165	-9,039	-837	104,888	-3,860	1,596	1,642	2,855	-4,769	-3,609	12,291	-3,792
Supplemental disclosures of cash flow information
Cash paid for interest
3,264	1,359	3,401	160	3,262	3,250	0	0	3,250	33	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cash paid for taxes, net
350	-	73	-128	57	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Interest paid
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	-	0	0	0	0	0
Cash paid for taxes, net
-	-	-	-	-	-	-	-	570	103	0	0	2	-4	0	0	4	-1	0	0	1	-	0	-	-	1	1	307	83	56	2	107	829	0	0
Non-cash investing activities
Non-cash investing activities and financing activities:
Purchases of property and equipment included in accounts payable
0	-2	-23	-78	113	100	21	1	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Right-of-use assets obtained in exchange for operating lease obligation
1,943	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Lease liabilities arising in exchange for right of use assets
1,945	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-